Economic evaluation of kidney transplantation versus hemodialysis in patients with end-stage renal disease in Hungary

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Background - Kidney transplantation is generally acknowledged as the more clinically effective and more cost-effective option in managing patients with end-stage renal disease, compared with dialysis. This study looked for confirmatory evidence in a Hungarian population. Methods - Patients (n = 242) with end-stage renal disease who received cadaveric kidney transplantation during 1994 were followed up for 3 years. They were compared with patients (n = 840) receiving hemodialysis who were on a waiting list for transplantation. Data were collected retrospectively. Treatments were compared for clinical efficacy and for cost-effectiveness. Results - At month 36, the standard mortality hazard function was 3.5 times higher in the group receiving hemodialysis (P

Original languageEnglish
Pages (from-to)188-193
Number of pages6
JournalProgress in Transplantation
Volume11
Issue number3
Publication statusPublished - 2001

Fingerprint

Hungary
Kidney Transplantation
Chronic Kidney Failure
Cost-Benefit Analysis
Renal Dialysis
Waiting Lists
Dialysis
Transplantation
Costs and Cost Analysis
Mortality
Population
Therapeutics

ASJC Scopus subject areas

  • Transplantation

Cite this

@article{8360d3aebea4450abe411c5c99845727,
title = "Economic evaluation of kidney transplantation versus hemodialysis in patients with end-stage renal disease in Hungary",
abstract = "Background - Kidney transplantation is generally acknowledged as the more clinically effective and more cost-effective option in managing patients with end-stage renal disease, compared with dialysis. This study looked for confirmatory evidence in a Hungarian population. Methods - Patients (n = 242) with end-stage renal disease who received cadaveric kidney transplantation during 1994 were followed up for 3 years. They were compared with patients (n = 840) receiving hemodialysis who were on a waiting list for transplantation. Data were collected retrospectively. Treatments were compared for clinical efficacy and for cost-effectiveness. Results - At month 36, the standard mortality hazard function was 3.5 times higher in the group receiving hemodialysis (P",
author = "Z. Kal{\'o} and J. J{\'a}ray and J. Nagy",
year = "2001",
language = "English",
volume = "11",
pages = "188--193",
journal = "Progress in Transplantation",
issn = "1526-9248",
publisher = "InnoVision Communications",
number = "3",

}

TY - JOUR

T1 - Economic evaluation of kidney transplantation versus hemodialysis in patients with end-stage renal disease in Hungary

AU - Kaló, Z.

AU - Járay, J.

AU - Nagy, J.

PY - 2001

Y1 - 2001

N2 - Background - Kidney transplantation is generally acknowledged as the more clinically effective and more cost-effective option in managing patients with end-stage renal disease, compared with dialysis. This study looked for confirmatory evidence in a Hungarian population. Methods - Patients (n = 242) with end-stage renal disease who received cadaveric kidney transplantation during 1994 were followed up for 3 years. They were compared with patients (n = 840) receiving hemodialysis who were on a waiting list for transplantation. Data were collected retrospectively. Treatments were compared for clinical efficacy and for cost-effectiveness. Results - At month 36, the standard mortality hazard function was 3.5 times higher in the group receiving hemodialysis (P

AB - Background - Kidney transplantation is generally acknowledged as the more clinically effective and more cost-effective option in managing patients with end-stage renal disease, compared with dialysis. This study looked for confirmatory evidence in a Hungarian population. Methods - Patients (n = 242) with end-stage renal disease who received cadaveric kidney transplantation during 1994 were followed up for 3 years. They were compared with patients (n = 840) receiving hemodialysis who were on a waiting list for transplantation. Data were collected retrospectively. Treatments were compared for clinical efficacy and for cost-effectiveness. Results - At month 36, the standard mortality hazard function was 3.5 times higher in the group receiving hemodialysis (P

UR - http://www.scopus.com/inward/record.url?scp=0034835409&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034835409&partnerID=8YFLogxK

M3 - Article

C2 - 11949461

AN - SCOPUS:0034835409

VL - 11

SP - 188

EP - 193

JO - Progress in Transplantation

JF - Progress in Transplantation

SN - 1526-9248

IS - 3

ER -